April 2, 2016 - The Steady Trader

Biotechnology Stocks Are Ripe For A Sharp Bounce

After a historically strong rally in recent years, Biotechnology stocks and the Nasdaq Biotechnology Index ETF (IBB) finally exhausted themselves in 2015 and began to tumble. So far in 2016 biotechnology has been on a one-way street lower but for the near-term increasingly look to be oversold. Active investors and Traders could look to play […]

Why the threat of recession makes it a great year for trading

You might think that seasoned equity trader Serge Berger is sitting at his desk with his head in his hands, after all it’s been a bleak start to the year. The S&P 500 has been smashed; with energy stocks seeing EPS down around 70% year on year. This earnings season has revealed even more wounding […]

Get Serge’s Daily Trading Tips

Want my tips and tricks to the markets? Subscribe and learn more about trading and investing, get an upper hand on the markets and on the path to a steadier trading and investing process. By subscribing you can expect to get anywhere from 2-4 new videos each week with clear, actionable, and relevant market commentary directly in your inbox. Not to mention you’ll be the first to know when we have upcoming Live Training Sessions. Enter your name and email and welcome to The Steady Trader family.

Trading contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing one’s financial security or lifestyle. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. Read our Full Disclaimers HERE.